KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neogenomics (NEO) Short-term Investments (2020 - 2025)

Historic Short-term Investments for Neogenomics (NEO) over the last 6 years, with Q2 2025 value amounting to $9.0 million.

  • Neogenomics' Short-term Investments fell 7265.18% to $9.0 million in Q2 2025 from the same period last year, while for Jun 2025 it was $9.0 million, marking a year-over-year decrease of 7265.18%. This contributed to the annual value of $19.8 million for FY2024, which is 7272.64% down from last year.
  • According to the latest figures from Q2 2025, Neogenomics' Short-term Investments is $9.0 million, which was down 7265.18% from $11.9 million recorded in Q1 2025.
  • Neogenomics' Short-term Investments' 5-year high stood at $203.0 million during Q2 2021, with a 5-year trough of $9.0 million in Q2 2025.
  • Its 5-year average for Short-term Investments is $116.0 million, with a median of $131.3 million in 2023.
  • Its Short-term Investments has fluctuated over the past 5 years, first skyrocketed by 30127.84% in 2021, then tumbled by 7753.8% in 2025.
  • Over the past 5 years, Neogenomics' Short-term Investments (Quarter) stood at $198.6 million in 2021, then dropped by 11.96% to $174.8 million in 2022, then tumbled by 58.4% to $72.7 million in 2023, then plummeted by 72.73% to $19.8 million in 2024, then tumbled by 54.81% to $9.0 million in 2025.
  • Its Short-term Investments was $9.0 million in Q2 2025, compared to $11.9 million in Q1 2025 and $19.8 million in Q4 2024.